nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alterations in serotype-specific B cell responses to the 13-valent pneumococcal conjugate vaccine in aging HIV-infected adults
|
Ohtola, Jennifer A. |
|
2016 |
34 |
4 |
p. 451-457 7 p. |
artikel |
2 |
Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge
|
Coria, Lorena M. |
|
2016 |
34 |
4 |
p. 430-437 8 p. |
artikel |
3 |
Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine
|
Mbawuike, Innocent N. |
|
2016 |
34 |
4 |
p. 547-554 8 p. |
artikel |
4 |
Commentary on: “Seasonal influenza vaccine dose distribution in 195 countries (2004–2013): Little progress in estimated global vaccination coverage”
|
Salisbury, David M. |
|
2016 |
34 |
4 |
p. 401-402 2 p. |
artikel |
5 |
Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity
|
Eichelberger, Maryna C. |
|
2016 |
34 |
4 |
p. 458-465 8 p. |
artikel |
6 |
Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells
|
Jing, Mingzhen |
|
2016 |
34 |
4 |
p. 516-522 7 p. |
artikel |
7 |
Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children
|
Kendall, Brian A. |
|
2016 |
34 |
4 |
p. 474-478 5 p. |
artikel |
8 |
Editorial Board/Aims and Scope
|
|
|
2016 |
34 |
4 |
p. IFC- 1 p. |
artikel |
9 |
Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets
|
Broadbent, Andrew J. |
|
2016 |
34 |
4 |
p. 563-570 8 p. |
artikel |
10 |
High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland
|
Waśko, Izabela |
|
2016 |
34 |
4 |
p. 510-515 6 p. |
artikel |
11 |
Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease
|
Pan, Qunxing |
|
2016 |
34 |
4 |
p. 578-585 8 p. |
artikel |
12 |
Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014
|
Pierse, Nevil |
|
2016 |
34 |
4 |
p. 503-509 7 p. |
artikel |
13 |
Intussusception risk with 116E rotavirus vaccine in Vellore, South India
|
Bajaj, Jalaj |
|
2016 |
34 |
4 |
p. 403- 1 p. |
artikel |
14 |
Modeling the hepatitis A epidemiological transition in Thailand
|
Van Effelterre, Thierry |
|
2016 |
34 |
4 |
p. 555-562 8 p. |
artikel |
15 |
Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands
|
Bosch, Astrid A.T.M. |
|
2016 |
34 |
4 |
p. 531-539 9 p. |
artikel |
16 |
Operational performance and analysis of two rabies vaccination campaigns in N’Djamena, Chad
|
Léchenne, Monique |
|
2016 |
34 |
4 |
p. 571-577 7 p. |
artikel |
17 |
Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection
|
Tabynov, Kaissar |
|
2016 |
34 |
4 |
p. 438-444 7 p. |
artikel |
18 |
Prime-boost vaccine strategy against viral infections: Mechanisms and benefits
|
Kardani, Kimia |
|
2016 |
34 |
4 |
p. 413-423 11 p. |
artikel |
19 |
Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains
|
Kim, Jin Hyang |
|
2016 |
34 |
4 |
p. 495-502 8 p. |
artikel |
20 |
Response to immunization in children born to renal transplant recipients using immunosuppressive drugs during gestation
|
Dinelli, Maria Isabel Saraiva |
|
2016 |
34 |
4 |
p. 404-407 4 p. |
artikel |
21 |
Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates
|
Pittman, Phillip R. |
|
2016 |
34 |
4 |
p. 523-530 8 p. |
artikel |
22 |
Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans
|
Pittman, Phillip R. |
|
2016 |
34 |
4 |
p. 424-429 6 p. |
artikel |
23 |
Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults
|
Santini-Oliveira, Marilia |
|
2016 |
34 |
4 |
p. 586-594 9 p. |
artikel |
24 |
Serological statuses of pregnant women in an urban Brazilian population before and after the 2008 rubella immunization campaign
|
Avila Moura, Adriana |
|
2016 |
34 |
4 |
p. 445-450 6 p. |
artikel |
25 |
Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets
|
Music, Nedzad |
|
2016 |
34 |
4 |
p. 466-473 8 p. |
artikel |
26 |
The confounded effects of age and exposure history in response to influenza vaccination
|
Mosterín Höpping, Ana |
|
2016 |
34 |
4 |
p. 540-546 7 p. |
artikel |
27 |
The potential acceptability of infant vaccination against malaria: A mapping of parental positions in Togo
|
Kpanake, Lonzozou |
|
2016 |
34 |
4 |
p. 408-412 5 p. |
artikel |
28 |
Trends in U.S. hospitalizations and inpatient deaths from pneumonia and influenza, 1996–2011
|
Chang, D.H. |
|
2016 |
34 |
4 |
p. 486-494 9 p. |
artikel |
29 |
Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design
|
Ali, Mohammad |
|
2016 |
34 |
4 |
p. 479-485 7 p. |
artikel |
30 |
WHO Strategic Advisory Group of Experts on immunization (SAGE): Request for nominations
|
|
|
2016 |
34 |
4 |
p. 595- 1 p. |
artikel |